Analyst Ratings for Dyne Therapeutics (DYN)
DYN Rating Summary
DYN Price Target Summary
- Highest: $47.00 (Oppenheimer)
- Lowest: $25.00 (JPMorgan)
- Average: $34.83
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$34.83 (+46.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$34.83 (+46.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/20/2024 | H.C. Wainwright | Andrew Fein | New Coverage | Buy (N/A) |
36.00 (N/A) |
22.91 (23.82) |
3.97% | Details |
| 2/27/2023 | Raymond James | Steven Seedhouse | Upgrade | Strong Buy (Outperform) |
27.00 (16.00) |
12.30 (23.82) |
93.66% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
